Over the last 90 days, prior to the date of this filing, there have been 44 insider transactions reported to the SEC for Incyte. These transactions came from the activities of 15 separate insiders that resulted in a net acquisition of 67,915 company shares. This compares with the preceding 90-day window of time where there were 29 transactions from 15 insiders which resulted in the net acquisition of 118,393 shares.
This level of insider transactions is higher than the peer group average for the 207-company Biotechnology & Medical Research peer group over the last 90-day period. Activity in the peer group averaged 38.9 transactions per company, with company insiders acquiring on average 23,682 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/879169/000120919119044574/xslF345X03/doc4.xml
|Streamline Health Solutions Sees Analysts Lower Fore...|
|Consensus Estimates for ReneSola's Q3, 2019, 2020 Ye...|
|2019, and 2020 Estimates for Sanofi Lowered but Q3 P...|
|Analysts' Scale Up 2019, 2020 Consensus Estimates fo...|
|Forecast for Sabra Health Care REIT's 2019 Earnings ...|